Daxor corporation announces non-government distribution agreement with concordance® healthcare solutions

New york, july 22, 2021 (globe newswire) -- daxor corporation (nyse mkt: dxr), the global leader in blood volume measurement technology, announces today that it has signed a non-government distribution agreement with concordance healthcare solutions, one of the largest independent healthcare distributors in the u.s. daxor and concordance will work together to provide daxor's bva-100® (blood volume analyzer) diagnostic blood test to healthcare facilities nationally, driving the use of blood volume measurement to help guide precise, individualized volume management in a wide variety of medical conditions including heart failure and critical care.
DXR Ratings Summary
DXR Quant Ranking